Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Lymphatic vessels develop from various cell types and mechanisms, not just veins.

The microenvironment, especially mechanical forces, plays a crucial role in hair growth and could lead to new treatments for hair loss.

Testosterone reduces key molecules needed for early pregnancy in rats.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Dutasteride is more effective than finasteride for hair growth, and sublingual apomorphine quickly improves Parkinson's symptoms.

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

Women have a higher DHT/testosterone ratio than men, possibly due to gut bacteria activity.

Protein ubiquitylation is crucial for controlling stem cell functions and could be targeted for cancer treatment.

PRP is effective for treating hair loss, especially with other treatments.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Adding a second method to PROTACs could improve cancer treatment.

Targeting amphiregulin may improve treatment for fibrosis and cancer.

5-alpha reductase inhibitors, like finasteride and dutasteride, may cause depression, but more research is needed to understand why.

EDA is vital for bone and cartilage formation and could help treat skeletal disorders.

WNT10B is important for body functions and linked to diseases like osteoporosis, obesity, and cancer.

New regenerative therapies show promise for treating hair loss.

OCT4 helps granulosa cell growth in early-stage follicles, and FSH increases OCT4 through specific pathways.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Standardizing light therapy methods could improve spinal cord injury treatment.

AVT is highly conserved and may have antimicrobial properties.

Environmental pollutants can damage hair health and cause hair loss.

Sebaceous glands age due to genetic and environmental factors, affecting sebum production and composition.

Researchers found genes linked to hair loss in male giant pandas.

DHT is needed for long-term depression, while E2 is needed for full long-term potentiation in male rat brains.